Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.5399
Delayed Data
As of Oct 16
 -0.0397 / -6.85%
Today’s Change
0.26
Today|||52-Week Range
2.15
-59.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$21.8M

Company Description

Repros Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of new drugs to treat hormonal and reproductive systems disorders. Its product pipeline is currently comprised of Enclophene and Proellex. The company was founded on August 20, 1987 and is headquartered in Woodlands, TX.

Contact Information

Repros Therapeutics, Inc.
2408 Timberloch Place
Woodlands Texas 77380
P:(281) 719-3400
Investor Relations:

Employees

Shareholders

Mutual fund holders8.67%
Individual stakeholders6.79%
Other institutional12.21%

Top Executives

Larry M. DillahaPresident, Chief Executive Officer & Director
Katherine A. AndersonCFO, Secretary & Principal Accounting Officer
Joachim F. WernickeChief Medical Officer